StageZero Life Sciences Ltd.

    StageZero Life Sciences Ltd.

    TTSX:SZLS
    - -
    CAD
    - -
    - -
    StageZero Life Sciences Ltd.
    TSX:SZLS
    (Toronto Stock Exchange)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2007
    2008
    2009
    2010
    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    TTM
    USD
    1.78
    0.94
    0.82
    0.12
    0.05
    0.12
    0.03
    0.38
    0.05
    0.13
    0.03
    0.01
    - -
    0.09
    0.07
    0.04
    0.02
    Revenue per Share
    -7.89
    -8.74
    -4.02
    -2.99
    -2.34
    -2.23
    -2.07
    -1.17
    -0.9
    -0.72
    -0.24
    -0.22
    -0.1
    -0.15
    -0.11
    -0.11
    -0.1
    Basic EPS, GAAP
    -8.69
    -6.47
    -3.48
    -1.53
    -1.52
    -1.78
    -1.02
    -0.27
    -0.26
    -0.46
    -0.32
    -0.2
    -0.14
    -0.07
    -0.13
    -0.04
    -0.01
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    11.19
    1.39
    1.62
    -0.09
    -0.16
    1.2
    0.32
    0.34
    -0.25
    -0.46
    -0.25
    -0.29
    -0.13
    -0.02
    0.03
    -0.07
    -0.07
    Book Value per Share
    10.87
    1.39
    1.62
    -0.09
    -0.16
    1.2
    0.32
    0.34
    -0.25
    -0.57
    -0.27
    -0.29
    -0.13
    -0.02
    -0.05
    -0.07
    -0.07
    Tangible Book Value per Share
    1
    1
    1
    2
    2
    2
    4
    6
    7
    8
    12
    17
    34
    45
    71
    99
    121
    Basic Weighted Avg Shares
    2
    1
    1
    - -
    - -
    - -
    - -
    2
    - -
    1
    - -
    - -
    - -
    4
    5
    4
    3
    Sales/Revenue/Turnover
    -475.65
    -948.51
    -447.98
    -2,098.59
    -3,788.62
    -1,552.42
    -4,153.89
    -99.07
    -874.93
    -404.56
    -1,252.9
    -2,510.83
    -3,567.44
    -80.81
    -160.43
    -206.43
    -153.57
    Operating Margin (%)
    1
    1
    1
    1
    1
    - -
    - -
    - -
    - -
    - -
    - -
    1
    - -
    - -
    1
    - -
    - -
    Depreciation Expense
    -10
    -11
    -5
    -5
    -4
    -5
    -9
    -7
    -6
    -6
    -3
    -4
    -3
    -7
    -7
    -11
    -13
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    -444.43
    -926.34
    -488.19
    -2,395.13
    -4,445.32
    -1,804.08
    -7,119.98
    -312.89
    -1,846.73
    -560.76
    -715.96
    -1,986.66
    -2,510.24
    -165.32
    -147.67
    -300.79
    -418.65
    Profit Margin (%)
    11
    - -
    2
    2
    2
    8
    2
    2
    -2
    -6
    -3
    -5
    -4
    2
    -2
    -7
    -8
    Working Capital
    1
    1
    3
    4
    4
    4
    - -
    - -
    - -
    - -
    1
    1
    1
    1
    1
    1
    1
    LT Debt
    14
    2
    2
    - -
    - -
    5
    2
    2
    -2
    -5
    -4
    -6
    -4
    -1
    3
    -8
    -9
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    -58.34
    -139.29
    -253.18
    - -
    - -
    - -
    -259.25
    -356.42
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    USD

    •

    in mil. unless spec.
    Mar'23
    Jun'23
    Sep'23
    ST Debt
    1
    1
    1
    LT Borrowings
    1
    1
    1
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    106
    123
    124
    Market Capitalization
    7
    6
    5

    Working Capital

    USD

    •

    in mil. unless spec.
    Mar'23
    Jun'23
    Sep'23
    Total Current Assets
    - -
    - -
    - -
    Cash, Cash Equivalents & STI
    - -
    - -
    - -
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    8
    8
    8
    Payables & Accruals
    6
    7
    7
    ST Debt
    1
    1
    1
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    -81.79%
    -147.98%
    -371.69%
    Free Cash Flow
    19.35%
    24.21%
    -61.24%
    Net Income, GAAP
    16.55%
    35.66%
    52.53%
    Sales/Revenue/Turnover
    452.17%
    562%
    -25.12%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    1
    1
    1
    1
    4
    2023
    - -
    - -
    1
    1
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    -0.01
    -0.01
    - -
    - -
    -0.11
    2023
    -0.01
    - -
    -0.01
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business